Findings

What do systematic reviews say?

4 questions · 9 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 11.1%Low 6 · 66.7%Moderate 2 · 22.2%High 0 · 0%

Complete cure and adverse events for terbinafine vs griseofulvin

Proportion of participants with complete cure · children with tinea capitis

Complete cure and adverse events for terbinafine showed no clear difference in proportion of participants with complete cure compared with griseofulvin (low certainty).

4 findings from 1 review

Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 1.06 [0.98, 1.15]
3 studies · 328 participants
Low
Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 1.18 [0.74, 1.88]
1 study · 1006 participants
Low
Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 0.68 [0.53, 0.86]
2 studies · 334 participants
Moderate

Show 1 more finding

Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 0.45 [0.15, 1.35]
1 study · 21 participants
Low

Complete cure for ketoconazole vs griseofulvin

Proportion of participants with complete cure · children infected with Trichophyton

Complete cure for ketoconazole showed no clear difference in proportion of participants with complete cure compared with griseofulvin (low certainty).

2 findings from 1 review

Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 0.92 [0.81, 1.03]
1 study · 62 participants
Low
Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 0.76
1 study · 62 participants
Low

Complete cure for fluconazole vs griseofulvin

Proportion of participants with complete cure · children with tinea capitis

Complete cure for fluconazole showed no clear difference in proportion of participants with complete cure compared with griseofulvin (moderate certainty).

2 findings from 1 review

Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 0.92 [0.81, 1.05]
3 studies · 615 participants
Moderate
Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 1.06 [0.77, 1.46]
1 study · 361 participants
Low

Complete cure for itraconazole vs griseofulvin

Proportion of participants with complete cure · children infected with Trichophyton and Microsporum

It is very uncertain whether complete cure for itraconazole changes proportion of participants with complete cure compared with griseofulvin (very low certainty).

1 finding from 1 review

Systemic antifungal therapy for tinea capitis in children 2016 · Cochrane Headline outcomes only
RR 0.92 [0.81, 1.05]
2 studies · 134 participants
Very low